Digestive Disease Interventions 2017; 01(04): 293-301
DOI: 10.1055/s-0038-1632364
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Plug-Assisted Retrograde Transvenous Obliteration

Eung Tae Kim
1   Department of radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Korea
,
Dong Il Gwon
1   Department of radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Korea
› Author Affiliations
Further Information

Publication History

22 February 2017

03 January 2018

Publication Date:
22 February 2018 (online)

Abstract

Gastric fundal varices and portosystemic hepatic encephalopathy are major complications of portal hypertension in patients with liver cirrhosis. Many treatment options have been used for gastric varices, including endoscopic injection and transjugular intrahepatic portosystemic shunts (TIPS), but the clinical effectiveness of these treatments remains contentious. Today, balloon-occluded retrograde transvenous obliteration (BRTO) has become the treatment of choice because of its excellent clinical effectiveness and outcomes; however, the associated use of sclerosants and temporary indwelling balloon catheters can cause specific complications. Vascular plugs are another option that has been shown to be safe, feasible, and effective when used as an embolic material in vascular disease. Recently, a technique has been developed that uses such vascular plugs with a gelatin sponge to embolize gastrorenal shunts. This technique is known as plug-assisted retrograde transvenous obliteration (PARTO), and it is also associated with high technical and clinical success rates. Moreover, it appears to be a much safer and more feasible procedure than BRTO. In this review, we introduce PARTO and outline its strengths and potential for use as the treatment of choice in gastric varices and hepatic encephalopathy.

 
  • References

  • 1 de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5 (03) 645-663
  • 2 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
  • 3 Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32 (04) 264-268
  • 4 Chandler JG, Fechner RE. Hepatopedal flow restoration in patients intolerant of total portal diversion. Ann Surg 1983; 197 (05) 574-583
  • 5 Uflacker R, Silva AdeO, d'Albuquerque LA, Piske RL, Mourão GS. Chronic portosystemic encephalopathy: embolization of portosystemic shunts. Radiology 1987; 165 (03) 721-725
  • 6 Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988; 95 (02) 434-440
  • 7 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11 (01) 51-58
  • 8 Gotoh Y, Iwakiri R, Sakata Y. , et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol 1999; 14 (03) 241-244
  • 9 Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33 (05) 1060-1064
  • 10 Ogawa K, Ishikawa S, Naritaka Y. , et al. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol 1999; 14 (03) 245-250
  • 11 Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995; 27 (05) 349-354
  • 12 Svoboda P, Kantorová I, Ochmann J, Kozumplík L, Marsová J. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices. Surg Endosc 1999; 13 (06) 580-584
  • 13 Rösch J, Keller FS. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives. World J Surg 2001; 25 (03) 337-345 , discussion 345–346
  • 14 Cello JP, Ring EJ, Olcott EW. , et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126 (11) 858-865
  • 15 Rössle M, Deibert P, Haag K. , et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349 (9058): 1043-1049
  • 16 Sanyal AJ, Freedman AM, Luketic VA. , et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112 (03) 889-898
  • 17 Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (brto): technical results and outcomes. Semin Intervent Radiol 2011; 28 (03) 333-338
  • 18 Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol 1996; 167 (05) 1317-1320
  • 19 Sonomura T, Sato M, Kishi K. , et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol 1998; 21 (01) 27-30
  • 20 Ninoi T, Nishida N, Kaminou T. , et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005; 184 (04) 1340-1346
  • 21 Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. Semin Intervent Radiol 2012; 29 (02) 118-128
  • 22 Cho SK, Shin SW, Lee IH. , et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007; 189 (06) W365-72
  • 23 Sabri SS, Swee W, Turba UC. , et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011; 22 (03) 309-316 , quiz 316
  • 24 Jang SY, Kim GH, Park SY. , et al. Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. Clin Mol Hepatol 2012; 18 (04) 368-374
  • 25 Choi SY, Won JY, Kim KA, Lee DY, Lee KH. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol 2011; 21 (01) 122-129
  • 26 Kumamoto M, Toyonaga A, Inoue H. , et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010; 25 (06) 1129-1135
  • 27 Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12 (03) 327-336
  • 28 Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211 (02) 349-356
  • 29 Cho SK, Shin SW, Yoo EY. , et al. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Korean J Radiol 2007; 8 (06) 520-530
  • 30 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001; 129 (04) 414-420
  • 31 Lee JY, Moon SH, Lee SM. , et al. A case of noncardiogenic pulmonary edema by ethanolamine oleate. Korean J Intern Med 1994; 9 (02) 125-127
  • 32 Park SJ, Chung JW, Kim HC, Jae HJ, Park JH. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Interv Radiol 2010; 21 (04) 503-507
  • 33 Shimoda R, Horiuchi K, Hagiwara S. , et al. Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts. Abdom Imaging 2005; 30 (03) 306-313
  • 34 Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988; 2 (8606): 340-341
  • 35 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics. Inc. 2002; 23 (04) 911-920
  • 36 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics 2003; 23 (04) 921-937 , discussion 937
  • 37 Wang W, Li H, Tam MD, Zhou D, Wang DX, Spain J. The amplatzer vascular plug: a review of the device and its clinical applications. Cardiovasc Intervent Radiol 2012; 35 (04) 725-740
  • 38 Lopera JE. The amplatzer vascular plug: review of evolution and current applications. Semin Intervent Radiol 2015; 32 (04) 356-369
  • 39 Rossi M, Rebonato A, Greco L. , et al. A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug. Cardiovasc Intervent Radiol 2006; 29 (05) 902-906
  • 40 Yoo H, Ko GY, Gwon DI. , et al. Preoperative portal vein embolization using an amplatzer vascular plug. Eur Radiol 2009; 19 (05) 1054-1061
  • 41 Gwon DI, Kim YH, Ko G-Y. , et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol 2015; 26 (11) 1589-1595
  • 42 Gwon DI, Ko G-Y, Yoon H-K. , et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration--a primary report. Radiology 2013; 268 (01) 281-287
  • 43 Park JK, Cho S-K, Kee S, Lee EW. Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy: a case report. Case Rep Radiol 2014; 2014: 391420
  • 44 Meyer BC, Frericks BB, Voges M. , et al. Visualization of hypervascular liver lesions during TACE: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol 2008; 190 (04) W263-9
  • 45 Virmani S, Ryu RK, Sato KT. , et al. Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 2007; 18 (10) 1305-1309
  • 46 Wang C, Wang Q, Chen W. , et al. DYNA CT arteriographic evaluation of hepatocellular carcinoma for treatment by trans-catheter arterial chemoembolization. Int J Clin Exp Med 2015; 8 (11) 20548-20555
  • 47 Lee EW, Saab S, Gomes AS. , et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol 2014; 5 (10) e61
  • 48 Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104 (01) 1-11 , discussion 12–15
  • 49 Han MH, Seong SO, Kim HD, Chang K-H, Yeon KM, Han MC. Craniofacial arteriovenous malformation: preoperative embolization with direct puncture and injection of n-butyl cyanoacrylate. Radiology 1999; 211 (03) 661-666
  • 50 Herman BE, Baum S, Denobile J, Volpe RJ. Massive bleeding from rectal varices. Am J Gastroenterol 1993; 88 (06) 939-942
  • 51 Hobbs JT. Surgery and sclerotherapy in the treatment of varicose veins. A random trial. Arch Surg 1974; 109 (06) 793-796
  • 52 Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94 (08) 925-936